We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Baby Teeth Found to Be Rich Source of Stem Cells

By Biotechdaily staff writers
Posted on 30 Apr 2003
Scientists have discovered that baby teeth, which children begin losing when they are six years old, contain a rich supply of stem cells in their dental pulp. More...
Their findings were reported in the April 21, 2003, online issue of the Proceedings of the National Academy of Sciences.

The discovery was made by a Dr. Songtao Shi, a scientist at the US National Institute of Dental and Craniofacial Research (NIDCR), who noticed tissue in an exfoliated baby tooth of his six-year-old daughter. He placed the tooth in a liquid medium used to culture cells and extracted the dental pulp. Soon after, he isolated living stem cells from the tissue, which led to the collection of more exfoliated teeth from children. He and his colleagues launched a round of studies to determine whether the cells would grow well in culture. They discovered that about 12-20 stem cells from each tooth had the ability to colonize and grow in culture.

Dr. Shi named the cells SHED (stem cells from human exfoliated deciduous teeth), to differentiate SHED from stem cells in adult tissues such as bone or brain. The researchers say the cells grow rapidly in culture and with prompting have the potential to induce the formation of specialized dentin, bone, and neuronal cells. If follow-up studies extend initial findings, SHED may be an important and easily accessible source of stem cells to repair damaged teeth, induce regeneration of bone, and treat neural injury or disease.

"Doctors have successfully harvested stem cells from umbilical cord blood for years,” said Dr. Shi. "Our finding is similar in some ways, in that the stem cells in the tooth are likely latent remnants of an early developmental process.”




Related Links:
National Institute of Dental and Craniofacial Research

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Influenza Virus Test
NovaLisa Influenza Virus B IgM ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.